Medwest
0832.180.420 · rovalta.com · 24/09/2026
ACTIVE
Medwest
Financial year 2025 · Closed on 31/12/2025
Net result190,4 k €+14,2 %over 1 year
Gross margin310,3 k €+3,1 %over 1 year
Equity937 k €+13,3 %over 1 year
Overview
Identity
Source · BCE/KBOMedwest is a Private limited company incorporated in 2010. Its main activity is: General medical practice activities. Its registered office is in Gent.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0832.180.420
- Incorporation
- 23/12/2010
- Legal form
- Private limited company
- Registered office
- Westergemstraat 183
9032 Gent · FlandreSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2025
Activities (NACE)
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 15 filingsTrend over 15 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 310,3 k € | +3.1% | 301 k € | +1.1% | 297,8 k € | +12.1% | 265,7 k € | +2.9% | 258,2 k € |
| EBITDA | 304,7 k € | +3.0% | 295,7 k € | +1.2% | 292,2 k € | +10.8% | 263,8 k € | +2.7% | 256,8 k € |
| Operating result | 251,7 k € | +2.9% | 244,6 k € | -0.2% | 245,1 k € | +14.3% | 214,4 k € | +3.9% | 206,4 k € |
| Net result | 190,4 k € | +14.2% | 166,7 k € | +11.1% | 150 k € | +1.4% | 148 k € | +11.8% | 132,4 k € |
| Balance sheet | |||||||||
| Equity | 937 k € | +13.3% | 827,1 k € | +14.4% | 723,1 k € | +10.1% | 656,5 k € | +13.7% | 577,5 k € |
| Total assets | 1 M € | +8.0% | 953 k € | +5.3% | 904,7 k € | +5.2% | 860,4 k € | +6.3% | 809,7 k € |
| Cash | 325 k € | +29.3% | 251,2 k € | +77.6% | 141,5 k € | -54.0% | 307,4 k € | +48.3% | 207,3 k € |
| Debts | 92,3 k € | -26.7% | 126 k € | -30.6% | 181,6 k € | -10.9% | 203,8 k € | -11.8% | 231,2 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20251 active · 3 ended
Active mandates
Jeroen Claeys
ActiveEnded mandates
Jeroen Claeys
EndedJeroen Claeys
EndedJeroen Claeys
EndedFinancials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 22/07/2026 | 04/09/2025 | 31/08/2024 | 31/08/2023 | 31/08/2022 | 30/08/2021 |
| General meeting | 15/05/2026 | 16/05/2025 | 17/05/2024 | 19/05/2023 | 20/05/2022 | 21/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 15 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 15/05/2026 | 22/07/2026 | Dutch | |
| Micro model | 31/12/2024 | 16/05/2025 | 04/09/2025 | Dutch | |
| Micro model | 31/12/2023 | 17/05/2024 | 31/08/2024 | Dutch | |
| Micro model | 31/12/2022 | 19/05/2023 | 31/08/2023 | Dutch | |
| Micro model | 31/12/2021 | 20/05/2022 | 31/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 21/05/2021 | 30/08/2021 | Dutch | |
| Micro model | 31/12/2019 | 15/05/2020 | 31/10/2020 | Dutch | |
| Micro model | 31/12/2018 | 17/05/2019 | 31/08/2019 | Dutch | |
| Micro model | 31/12/2017 | 18/05/2018 | 24/08/2018 | Dutch | |
| Micro model | 31/12/2016 | 19/05/2017 | 25/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 20/05/2016 | 01/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 15/05/2015 | 25/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 16/05/2014 | 26/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 17/05/2013 | 30/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 18/05/2012 | 05/02/2013 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 3 ended
Active mandates
Jeroen Claeys
ActiveEnded mandates
Jeroen Claeys
EndedJeroen Claeys
EndedJeroen Claeys
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025190,4 k €↑
- 2024Annual accounts 2024166,7 k €↑
- 2024Name changeMedwest
- 2023Annual accounts 2023150 k €↑
- 2022Annual accounts 2022148 k €↑
- 2021Annual accounts 2021132,4 k €↑
- 2021Name changeClaeys Jeroen, Huisarts
- 2020Annual accounts 2020114,4 k €↑
- 2019Annual accounts 201980,4 k €↓
- 2018Annual accounts 201883 k €↓
- 2017Annual accounts 201783,5 k €↑
- 2016Annual accounts 201669,5 k €↑
- 2015Annual accounts 201567,5 k €↑
- 2014Annual accounts 201467,5 k €↑
- 2013Annual accounts 201344,3 k €↓
- 2012Annual accounts 201251,2 k €↑
- 2011Annual accounts 201143,6 k €
- 23/12/2010IncorporationPrivate limited company